Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia

5 Nov 2014

Abstract excerpt

The concept of leukaemic stem cells (LSCs) has been developed to explain the complex cellular hierarchy and biology of leukaemias and to screen for pivotal targets that can be employed to improve drug therapies through LSC eradication in these patients. Some of the newly discovered LSC markers seem to be expressed in a disease-specific manner and may thus serve as major research tools and diagnostic parameters. A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Myeloid Leukemia Treatments
Share to Neuroendocrine Tumor Research Advances
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25371066
DOI: 10.1111/eci.12368

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemiaPMID 25371066Read ↗

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemiaSemantic proximity Read ↗

Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid LeukemiaSemantic proximity Read ↗

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspectsSemantic proximity Read ↗

CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL.Semantic proximity Read ↗

Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)Semantic proximity Read ↗

CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune DisordersSemantic proximity Read ↗

Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice.Semantic proximity Read ↗

Apheresis-related enrichment of CD26++ T lymphocytes: phenotypic characterization and correlation with unfavorable outcome in autologous hematopoietic progenitor cell transplantation.Semantic proximity Read ↗

Targeting Cathepsin-G to Overcome Leukemic Stem Cell Persistence in Chronic MyeloidSemantic proximity Read ↗

T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition.Semantic proximity Read ↗

Structural Requirements for Catalysis, Expression, and Dimerization in the CD26/DPIV Gene FamilySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.